Avivit Cahn
Overview
Explore the profile of Avivit Cahn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
5129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsur A, Cahn A, Hanoch L, Pollack R
Diabetes Obes Metab
. 2025 Mar;
PMID: 40084557
Aim: Diabetic kidney disease (DKD) is a major complication of diabetes, including in insulin-deficient phenotypes, yet data on kidney outcomes with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in this population are...
2.
Hershkowitz I, Moss J, Sosna J, Netser E, Cahn A, Hershko A
Isr Med Assoc J
. 2025 Feb;
27(1):42-48.
PMID: 39931005
Background: Management of patients with reported iodinated contrast media (ICM) allergy is not supported by sufficient data. It is assumed that these patients are at risk for severe reactions, and...
3.
Tsur A, Cahn A, Levy L, Pollack R
JBMR Plus
. 2024 Dec;
9(1):ziae146.
PMID: 39687784
Romosozumab is a potent treatment for osteoporosis, with significant effects on bone density and fracture prevention. This study evaluated the cardiovascular safety of romosozumab in a real-world cohort of postmenopausal...
4.
Bar Ziv O, Cahn A, Jansen T, Istomin V, Kedem E, Olshtain-Pops K, et al.
J Infect Dis
. 2024 Apr;
230(2):411-420.
PMID: 38557867
Diabetes mellitus (DM) is more common among people living with human immunodeficiency virus (PLWH) compared with healthy individuals. In a prospective multicenter study (N = 248), we identified normoglycemic (48.7%),...
5.
Tsur N, Frankel M, Cahn A, Tsur A
J Diabetes Complications
. 2024 Mar;
38(4):108720.
PMID: 38452402
Aim: To investigate ethnic disparities in risk of gestational diabetes-mellitus (GDM) and future diabetes. Methods: A population-based retrospective cohort study of women who underwent a 100-g oral glucose-tolerance-test (oGTT) during...
6.
Hershkowitz I, Cahn A, Haran T, Hershko A
Isr Med Assoc J
. 2024 Feb;
26(1):54-55.
PMID: 38420645
No abstract available.
7.
Ibrahim M, Ba-Essa E, Baker J, Cahn A, Ceriello A, Cosentino F, et al.
Diabetes Metab Res Rev
. 2023 Dec;
40(3):e3755.
PMID: 38115715
In the primary care setting providers have more tools available than ever before to impact positively obesity, diabetes, and their complications, such as renal and cardiac diseases. It is important...
8.
Cahn A, Mor-Shaked H, Rosenberg-Fogler H, Pollack R, Tolhuis B, Sharma G, et al.
Eur J Hum Genet
. 2023 Dec;
32(2):232-237.
PMID: 38086948
Severe insulin resistance syndromes result from primary insulin signaling defects, adipose tissue abnormalities or other complex syndromes. Mutations in TBC1D4 lead to partial insulin signaling defects, characterized mainly by postprandial...
9.
Hershkowitz I, Cahn A
Lancet Healthy Longev
. 2023 Sep;
4(10):e522-e523.
PMID: 37734396
No abstract available.
10.
Perzon O, Cahn A, Gellman Y, Leibovitch M, Peled S, Elishoov O, et al.
Open Forum Infect Dis
. 2023 May;
10(5):ofad238.
PMID: 37234514
Background: Diabetic foot infections (DFIs) are frequently polymicrobial, yet the relevance of each isolated pathogen, remains ill-defined. Specifically, the prevalence and pathogenicity of enterococcal DFIs and the impact of targeted...